Glioma induces atypical depression-like behaviors in mice through the 5-HT and glutamatergic synapse pathways

Copyright © 2024 Elsevier Inc. All rights reserved..

Glioma patients often undertake psychiatric disorders such as depression and anxiety. There are several clinical epidemiological studies on glioma-associated depression, but basic research and corresponding animal experiments are still lacking. Here, we observed that glioma-bearing mice exhibited atypical depression-like behaviors in orthotopic glioma mouse models. The concentrations of monoamine neurotransmitters were detected by enzyme-linked immunosorbent assay (ELISA), revealing a decrease in 5-hydroxytryptamine (5-HT) levels in para-glioma tissues. The related gene expression levels also altered, detected by quantitative RT-PCR. Then, we developed a glioma-depression comorbidity mouse model. Through sucrose preference test (SPT), forced swimming test (FST), tail suspension test (TST) and other tests, we found that the occurrence of glioma could lead to changes in depression-like behaviors in a chronic unpredictable mild stress (CUMS) mouse model. The results of RNA sequencing (RNA-seq) indicated that the altered expression of glutamatergic synapse related genes in the paratumor tissues might be one of the main molecular features of the comorbidity model. Our findings suggested that the presence of glioma caused and altered depression-like behaviors, which was potentially related to the 5-HT and glutamatergic synapse pathways.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:704

Enthalten in:

Biochemical and biophysical research communications - 704(2024) vom: 16. März, Seite 149706

Sprache:

Englisch

Beteiligte Personen:

Li, Boyang [VerfasserIn]
Ran, Kunnian [VerfasserIn]
Jing, Zefan [VerfasserIn]
Han, Wei [VerfasserIn]
Peng, Xiaozhong [VerfasserIn]

Links:

Volltext

Themen:

333DO1RDJY
5-HT
Antidepressive Agents
CUMS
Depression
Glioma
Glutamatergic synapse
Journal Article
Serotonin

Anmerkungen:

Date Completed 13.03.2024

Date Revised 13.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.bbrc.2024.149706

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369220161